T hree features of peripheral T cell tolerance, namely, clonal deletion, clonal anergy, and suppression, have been identified. These processes do not work independently but represent components of a larger mechanism that involves combined activities. In several model systems, tolerance of peripheral T cells can be induced by inoculation of antigen in vivo. Injection of minor lymphocyte-stimulating antigen 1 a (Mls-1 a ) spleen cells or Staphylococcal enterotoxin B into mice induces the transient expansion of T cells expressing reactive V␤ T cell receptor (TCR) during the first 3-4 days after injection, followed by a reduction in the number of these cells. This latter process is a form of clonal deletion (1) (2) (3) (4) (5) (6) . However, not all specific T cells are eliminated, and a majority of the remaining T cells become anergic to TCR stimulation (6) (7) (8) . Our laboratory has used TCR V␤8.1 transgenic mice and the Mls-1 a antigen to study T cell tolerance in the periphery as well as central tolerance to a self-antigen (7) (8) (9) (10) . Tolerant T cells obtained from Mls-1 a -inoculated TCR V␤ 8.1 transgenic mice display hyporesponsiveness to antigen restimulation in vitro, and proteins from these cells showed altered tyrosine phosphorylation patterns after TCR engagement (7) . In addition, hyporesponsiveness induced to Mls-1 a also led to delayed allograft rejection in vivo (10 
CD4
ϩ T cells in peripheral T cell regulation. This report also clearly shows that the hyporesponsiveness resulting from suppression is a distinct mechanism from the anergic state induced after antigen sensitization and that these two distinct mechanisms act simultaneously in the maintenance of tolerance in vivo. ) mice were obtained from The Jackson Laboratory. TCR V␤8.1 transgenic mice were bred onto a CBA͞Ca background and express the transgene on greater than 98% of peripheral T cells (7, 11) .
Materials and Methods
Antibodies. Hybridomas that produce the following mAbs were purchased from the American Type Culture Collection (Manassas, VA): GK1.5 (anti-CD4), 3.155 (anti-CD8), 14-4-4s (anti-I-E 11B11 (anti-mouse IL-4), 7D4 (anti-mouse IL-2R␣, p55), and R4-6A2 (anti-mouse IFN-␥). Culture supernatants of these cells were used for experiments; some were purified further by protein G column chromatography. The hybridoma SM6C10 was a gift of K. Hayakawa (Fox Chase Cancer Center, Philadelphia) (19) (20) (21) . FITC and biotin-conjugated anti-CD25 (7D4) and anti-CD25 mAb, which react with distinct epitopes of the IL-2R␣ (PC61), were obtained from PharMingen. Phycoerythrin anti-CD4 (clone H129.19; GIBCO͞BRL) and FITC anti-mouse IgM (Southern Biotechnology Associates) also were used for flow cytometry studies. Neutralizing antibodies of anti-mouse IL-10 (clone 2A5; Endogen, Cambridge, MA), anti-transforming growth factor (TGF)-␤1, ␤2, and ␤3 (R&D Systems), anti-FasL (clone K10; PharMingen), anti-CD40L (clone MR1; PharMingen), isotype control mouse IgG (anti-KLH; PharMingen), and control rat IgG (Sigma) were used for blocking studies.
Tolerance Induction in Vivo. Tolerance to Mls-1 a was induced as described previously with some modification (7, 11) . Briefly, Mls-1 a T cell-depleted spleen cells were prepared by treatment of CBA͞J spleen cells with anti-Thy 1.2 mAb (30-H12) and rabbit H-2 complement (Pel-Freez Biologicals) followed by centrifugation over a cushion of Lympholyte M (Cedarlane Laboratories). Fifteen million T cell-depleted spleen cells were injected i.v. twice into V␤8.1 transgenic mice in a 7-day period.
Cell Preparation for Proliferation Assays. The inguinal, popliteal, brachial, and axillary lymph nodes and the spleens were harvested from control uninoculated and inoculated V␤8. Cytokine ELISA. IL-2 in culture supernatants was quantified by ELISA by using two distinct, anti-mouse IL-2 mAbs (JES6-1A12 as the capture antibody and JES6-5H4 as the detection antibody; PharMingen). Recombinant mouse IL-2 (Roche, GipfOberfrick, Switzerland) was used as a standard. The lower limit of the detection was 49 pg͞ml. (Fig. 1B) . Proliferation of naive splenic CD4 ϩ T cells is inhibited by the addition of tolerant splenic CD4 ϩ T cells in a dose-dependent manner. On the other hand, lymph node CD4 ϩ T cells from tolerant mice mediated only minimal inhibition of the proliferation of naive lymph node CD4 ϩ T cells. Percentage suppression by splenic CD4 ϩ T cells from tolerant mice that were injected with Mls-1 a antigen twice was significantly greater than that of singly injected mice (85.4 Ϯ 10.4%, n ϭ 13, and 68.3 Ϯ 10.3%, n ϭ 7, at 1:1 mixture, respectively; P Ͻ 0.05 by t test). To examine whether populations other than CD4 ϩ T cells in the tolerant mice mediate suppression, CD4 ϩ , CD8 ϩ , and DN cells were enriched and tested for suppressive effect (Fig. 1C) . Notably, all fractions of the tolerant cells were unable to proliferate to Mls-1 a antigen. However, only CD4 ϩ and the whole population mediated suppression, whereas the CD8 ϩ and DN fraction in which CD4 ϩ T cells were deleted did not have any discernible effect. This result indicates that only CD4 ϩ T cells mediate suppressive activity.
Results

Tolerant CD4 ؉ T Cells Suppress IL-2 Production by Naive CD4 ؉ T Cells in Vitro, and Exogenous IL-2 Abrogates Active Suppression but Does
Not Stimulate Anergic T Cells. IL-2 production by naive CD4 ϩ T cells cocultured with or without tolerant CD4 ϩ T cells was measured ( Fig. 2A) . IL-2 in the supernatants of naive CD4 ϩ T cells stimulated with Mls-1 a was detected as early as 1 day after antigen stimulation and reached a maximum on day 3, whereas IL-2 production by tolerant CD4 ϩ T cells was lower than the detection limit throughout the culture period. In mixed cultures of naive CD4 ϩ T cells and tolerant CD4 ϩ T cells, IL-2 production by naive CD4 ϩ T cells also was reduced dramatically (Fig. 2 A) .
We examined the effect of exogenous IL-2 on the hyporesponsiveness and suppressive effect of tolerant CD4 ϩ T cells. Suppression by tolerant CD4 ϩ T cells could be abrogated completely by the addition of exogenous IL-2 in a dosedependent manner (Fig. 2B) . However, the proliferation of tolerant CD4 ϩ T cells did not recover even in the presence of a high concentration of IL-2.
Suppression Mediated by CD4 ؉ T Cells Requires Cell Contact. Suppression by tolerant CD4 ϩ T cells was not neutralized with antibodies against various known inhibitory cytokines such as IL-4, IL-10, IFN-␥, and transforming growth factor ␤ (TGF-␤) (Fig. 3A) . In addition, nitric oxide inhibitors had no effect on the suppression (data not shown). IL-4 secretion by tolerant CD4 ϩ T cells was not detected, and IL-10 production was lower than control naive CD4 ϩ T cells (data not shown). To examine the possibility of a soluble factor other than these inhibitory cyto-kines, tolerant CD4 ϩ T cells and naive CD4 ϩ T cells were separated in the same culture well by a membrane (Fig. 3B) . Suppression by tolerant CD4 (Fig.  3C) , suggesting the necessity of cell contact with the target responding cells on the antigen-presenting cell (APC). Cell contact-dependent suppression undoubtedly requires a cell surface molecule that can affect naive CD4 ϩ T cells. We have examined the likely candidates, FasL and CD40L. Blocking antibodies against FasL and CD40L, however, failed to affect suppression (data not shown).
As a next step, we examined whether tolerant CD4 ϩ T cells mediated suppression simply by competition with responding naive CD4 ϩ T cells for the MHC-antigen complex or costimulatory molecules on the same APC. Naive CD4 ϩ T cells and tolerant CD4 ϩ T cells were cocultured with an increasing number of Mls-1 a T-depleted spleen cells (Fig. 4A) . The extent of the suppression decreased in proportion to increasing the number of stimulators. However, suppression was never abolished completely. Tolerant CD4 ϩ T cells still mediated 55% of the expected suppression even in the presence of an 80-fold excess of APC (40 ϫ 10 5 ͞well of Mls-1 a T-depleted spleen cells). Therefore, it is unlikely that the mechanism of the suppression can be explained by passive interference. In addition, CD80, CD86, and MHC class II expressions on the APC cocultured with tolerant CD4 ϩ T cells were not decreased (data not shown). Therefore, suppression was not caused by down-modulation of known costimulatory molecules on the APC population.
Although suppressor cells appear to require cell contact on the APC, it is unclear whether suppressor cells need to be stimulated through TCR for induction of the suppression. Therefore, in an attempt to show that activation of the suppressor cells requires TCR stimulation, we examined the suppressive effect of tolerant CD4 ϩ T cells in an allogeneic response (Fig. 4B) . Tolerant CD4 The purity of each fraction was as follows: CD4 ϩ fraction (CD4 ϩ Ͼ 75%, CD8 ϩ Ͻ 0.05%), CD8 ϩ fraction (CD4 ϩ Ͻ 0.05%, CD8 ϩ Ͼ 65%), and DN fraction (CD4 ϩ Ͻ 0.05%, CD8 ϩ Ͻ 0.05%). The experiment was repeated three times. (Fig. 5B) .
The anergic state of lymph node CD4 ϩ T cells in tolerant mice correlates well with the loss of expression of the T cell differ- entiation marker, 6C10 (11) . Expression of 6C10 on lymph node CD4 ϩ T cells was reduced drastically to less than 25% in tolerant mice, whereas 60-80% of naive lymph node CD4 ϩ T cells express 6C10 (11) . A decrease of 6C10 ϩ cells persisted for at least 1 month after inoculation, and functional analysis showed that the remaining 6C10 ϩ CD4 ϩ lymph node T cells in tolerant mice retained a proliferative response, whereas 6C10 Ϫ CD4 ϩ T cells continued to be hyporesponsive (11) . To examine whether CD25 
Discussion
Evidence from numerous model systems has demonstrated the role of cell-mediated suppression in peripheral T cell tolerance. Our efforts to understand suppressor T cells and their factor(s) began several years ago and have continued to some extent in several systems (22) (23) (24) (25) . Recent interest in this area once again is obvious. Suppressor populations have been shown to include CD4, CD8, double-negative cells, and APC (26) (27) (28) (29) (30) (31) , suggesting several distinct mechanisms of suppression. Regulatory cytokines and soluble factor(s) produced by suppressor cells have been reported in various models of autoimmune or inflammatory diseases (28, (32) (33) (34) (35) (36) . Suppression that requires cell-cell contact at the level of the APC also has been reported (14, 16, 26, 37) . Recently, CD25 ϩ CD4 ϩ T cells, ''natural'' anergic͞ suppressor cells, have been found to be relevant to the prevention of organ-specific autoimmune disease (12) (13) (14) (15) (16) . The CD25 ϩ CD4 ϩ suppressor population regulates self-reacting T cells that have escaped thymic-negative selection and are found in the periphery. Suppressor cells found in our system require cell contact for suppression (Fig. 3B) , and exogenous IL-2 completely abrogates suppression (Fig. 2B) . These data are consistent with previous reports on the biology of CD25 ϩ CD4 ϩ T cells (14, 16) . Nevertheless, CD25 6A ) and exogenous IL-2 was added to the culture (Fig. 6B) . Because exogenous IL-2 completely rescues suppression mediated by tolerant CD4 ϩ T cells (Fig. 2B) Although reduced expression of the 6C10 antigen correlates with the anergic state induced in antigen-inoculated mice (11, 41) , the molecular mechanisms underlying this expression pattern is unknown. The 6C10 antigen has been thought to be a carbohydrate epitope on Thy-1 glycoprotein and is expressed on approximately 90% of thymocytes and 60-80% of peripheral T lymphocytes (11, (19) (20) (21) . Because the Thy-1 glycoprotein is a glycosylphosphatidylinositol-anchored protein bound to lipid rafts on the cytoplasmic membrane (19) (20) (21) , it is conceivable that the 6C10 antigen could normally facilitate the accumulation of signaling molecules at the site of TCR stimulation. Involvement of Thy-1 antigens in T cell activation, in fact, has been demonstrated in several systems (42) (43) (44) 6C10 antigen may relate to the biological alteration or disorganization of the much larger T cell signaling complex in anergic T cells.
Suppressor cells in our system require cell contact to mediate inhibition. Failure of suppression after stimulation with immobilized anti-CD3 mAb also suggests the requirement of cell contact at the APC. Although it remains to be clarified whether suppressor cells affect naive CD4 ϩ T cells directly or by modulating the function of the APC, it is apparent that regulation by CD25 ϩ CD4 ϩ T cells is executed at the site of antigen presentation in the periphery. We have suggested previously that some APCs that survive UV radiation in mice induce suppressor T cells (31) . This type of APC might be involved in peripheral T cell regulation by inducing or activating suppressor T cells. Therefore, it is also possible that some APCs that interact with suppressor T cells might have a regulatory role in this system.
An active role of suppression has been demonstrated clearly in adoptive transfer models in vivo (25, 27) . In contrast, it has been difficult to show whether unresponsiveness in anergic cells is functionally independent from suppression in tolerant animals. In this report, we have demonstrated clearly that the anergic state after antigen exposure in vivo is not brought about solely by suppressor T cells. In addition, we have shown that suppressor T cells apparently contribute to the down-regulation of nonanergic CD4 ϩ T cells in situ in tolerant mice. Suppressor T cells, therefore, may inhibit the nonanergic cells remaining in the periphery as well as newly emerging T cells and, synergistically with anergic cells, maintain the unresponsive state induced after excessive antigen sensitization. Our present study suggests a physiological role of suppressor T cells in lymphocyte homeostasis in vivo.
